NEWS The Fosciclopirox Story ELIAS Animal Health announces appointment of Tammy Ham to Board of Directors, 3/18/2020 Read A good start for fosciclopirox, DD News, March 2020 Read CicloMed Presents New Oncology Data from Phase I Trial with Fosciclopirox at 2020 ASCO Genitourinary Cancers Symposium, Globe Newswire, 2/13/2020 Read 2020 Startups to Watch: ELIAS Animal Health wags past milestones in cancer treatment for dogs, Startland News, 1/22/2020 Read CicloMed Expands Fosciclopirox Phase 1 Trial, Drug Development & Delivery, 12/4/2019 Read CicloMed Expands Fosciclopirox Phase 1 Trial to Include Cisplatin-Ineligible Muscle-Invasive Bladder Cancer Patients, Globe Newswire, 12/3/2019 Read Florida EHR provider acquires KC health software company, Kansas City Business Journal, 6/24/2019 Read KU partnership will fill 'soaring' need for behavioral health professionals, Kansas City Business Journal, 7/2/2018 Read Behavioral Health Holdings, KU Edwards Campus Collaborate to Serve Kansas City Area’s Autism Community, University of Kansas, 6/22/2018 Read CicloMed Announces ASCO 2018 Presentation on Clinical Trial for Ciclopirox Prodrug, Under Development for Bladder Cancer, Globe Newswire, 5/31/2018 Read Antifungal ‘prodrug’ shows promise in bladder cancer: AACR, Fierce Biotech, 4/16/2018 Read CicloMed Announces Presentation of Preclinical Evidence for its Bladder Cancer Agent at AACR 2018 Meeting, Globe Newswire, 4/12/2018 Read CicloMed Announces First Patient Dosed With Ciclopirox Prodrug in Phase I Trial, Drug Development & Delivery, 3/6/2018 Read KU Med, VC partnership bridges the gap between research and treatment, Kansas City Business Journal, 10/18/2017 Read KC biotech developing KU cancer drug clears big FDA hurdle, Kansas City Business Journal, 10/11/2017 Read KU Cancer Center, Children's Mercy collaboration will boost NCI effort, Kansas City Business Journal, 1/25/2017 Read U of Kansas Medical Center partners with BioNovus to advance health technologies, Tech Transfer eNews Blog, 5/11/2016 Read VC firm develops first KU-invented cancer drug; FDA plans near, Kansas City Business Journal, 5/10/2016 Read IAMI partners with BioNovus to develop bladder cancer drug, KU Medical Center News, 5/9/2016 Read KU, new VC fund join to speed biotech, pharma commercialization, Kansas City Business Journal, 5/4/2016 Read BioNovus Innovations and the University of Kansas Medical Center's Institute for Advancing Medical Innovation Announce Partnership, PR Newswire, 5/3/2016 Read Behavioral health startup announces acquisition, name change, Startland News, 3/1/2016 Read
